Approvals/TGA/ADALICIP adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen

Approved

STANDARD

ADALICIP adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6d00085633c19c94
Product Name: ADALICIP adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen
Artg Id: 374376
Artg Name: ADALICIP adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2022-09-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/6e8b9d78269ed91ec4f3b255105608e4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/bfb1e01c08b0eb256229d352fa5c3c88.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

6d00085633c19c94

Type

Standard